Alector
ALEC | NASDAQ
$2.57
+$0.03 (+1.18%)
At close: Nov 16, 2026, 4:00 PM ET
$2.52
-$0.05 (-1.95%)
After-hours:
Nov 16, 2026, 7:53 PM ET
+1.18%
(1D)No price chart data available for 1D timeframe.
Rating
81.5
Fundamentals Excellent
Market Sentiment Bullish
Moat None
Sector Rank #14/1021 (Top 1%)
Key Statistics
Market Data
Market Cap $382.61M
1D Range
2.52 2.66
52W Range
1.14 2.72
Valuation (TTM)
PE 7.14
PB 3.28
EV/EBITDA 5.85
Valuation (NTM)
Forward PE 4.46
Forward PEG -0.05
Price Target $3.00
Cash Flow
FCF Yield -39.2%
SBC Adj. FCF Yield -42.4%
SBC Impact -8.2%
Margins
Gross Margin 100.0%
Operating Margin 20.2%
FCF Margin -86.5%
Growth (CAGR)
Revenue 3Y | 5Y 21.7% |
-2.6%
Dil EPS 3Y | 5Y 128.2% |
40.5%
FCF 3Y | 5Y 19.0% |
-16.5%
Returns
ROA 25.0%
ROE 112.2%
ROIC 24.8%
Financial Health
Net Cash
$117.7M
Current Ratio 4.10
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally ...
Sector Healthcare
Industry Biotechnology
Employees 103
IPO Date Feb 7, 2019
Website www.alector.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
$1.11
Beat +591.41%
YoY:
+426.47% REV
$162.87M
Beat +6743.11%
YoY:
+4895.89%Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$3.00
Upside
+16.73%
Buy (3)
Hold (0)
Sell (1)
Add to Watchlist
Select watchlists to add or remove ALEC